Cryptococcosis: An unusual opportunistic infection complicating B cell lymphoproliferative disorders

Journal of Infection

Volumn 36, Issue 2, 1998, Pages 220-222

  Melzer, M ^a   Colbridge, M ^a   Keenan, F ^b   Stainsby, D ^b   Ong, E L C ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b Sunderland General Hospital   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0007462054     PISSN: 01634453     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0163-4453(98)80018-2     Document Type: Article

References (7)

1. Schurmann D, de Matos Marques B, Grunewald T et al. Safety and efficacy of Liposomal Amphotericin B in treating AIDS-associated disseminated cryptococcosis. J Infect Dis 1991; 164: 620-622.
2. Cohen J, Denning DW, Hay RJ, Mackenzie, DWR. Prentice AG, Rogers TRF et al. Antifungal chemotherapy in patients with acquired immunodeficiency syndrome. Lancet 1992; 340: 649-651.
3. Duncan RA, Van Reyn CF, Alliegro GM, Toossi Z, Sugar AM, Levitz SM. Idiopathic CD4+ T-lymphocytopenia -four patients with opportunistic infection and no evidence of HIV infection. N Engl J Med 1993; 328: 393-398.
4. Rowland LG, Griffiths CO. Myasthenia gravis, thymoma and cryptococcal menigitis. New Engl J Med 1965 ; 620: 273.
5. Hurd DD, Stanb DB, Roelofs RI, Dehner LP. Profound muscle weakness as the presenting feature of disseminated cryptococcal infection in a patient with CLL. R Infect Dis 1989; 11: 970-974.
6. Isek M, Anzo M, Yamashita N, Matsuo N. Hyper IgM Immunodeficiency with disseminated cryptococcosis. Acta Paediatrica 1994; 83: 780-782.
7. Mukherjee J, Casadevall A, Scharff MD. Molecular characterisation of the humoral responses to Cryptococcus neoformans infection and glucuronoxylomannan-tetanus toxoid conjugate immunisation. J Exp Med 1993; 177: 1105-1116.